Grant directory

Open

Funds academic institutions to become long-term FDA partners researching bird flu, animal genomics and unmet veterinary needs.

Open

Supports the CFI Northern Fund continuous grants for northern Canadian institutions creating research infrastructure led by local communities.

Open

Funds discovering and developing a medication or device to prevent or treat substance use disorders and overdose, in two phases.

Open

Funds natural-history studies that improve preparedness for rare disease trial pathways.

Open

Funds early-stage work to find a method or agent that hits a human disease target considered undruggable.

Open

Funds phased clinical research programs for Down syndrome interventions through developmental and expansion awards.

Open

Supports early-stage exploratory Down syndrome studies through investigator grants advancing transformative research in the United States.

Open

Funds transformative Down syndrome research through investigator-led grants focused on evidence-based development.

Open

Funds planning then running a milestone-driven clinical trial for a health condition that co-occurs with Down syndrome.

Open

Funds early, exploratory Down syndrome research — a novel idea or new use of an existing method, even where the answer is unproven.

Open

Funds bold, unconventional Down syndrome research that could open an entirely new scientific or clinical direction.

Open

Capital grants for large-scale UK life sciences R&D investments.

Open

Funds a single NIGMS investigator's whole research program with one grant, instead of juggling several project-specific awards.

Open

Funds no new studies directly — it grants approved investigators access to NIH's shared genetic and multi-omics data on heart, lung, blood and sleep disorders.

Open

Funds an early-stage, high-risk project that includes a clinical trial — and at some institutes only a mechanistic one counts.

Open

Funds a defined research project in the investigator's own area of expertise, through the announcement most NIH institutes keep permanently open.

Open

Funds a small project that can be finished quickly with limited resources — a pilot, a reanalysis, a method, or a piece of new research technology.

Open

Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.

Open

Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.

Open

Supports investigator-led studies on workplace health disparities and occupational risk in the United States.

Open

Funds functional testing of genetic variants linked to congenital anomalies, to separate the ones that matter from the ones that merely appear.

Open

Funds buying one commercially available research instrument new to the institution, shared across users, from $50,000 up to $400,000.

Open

Funds a shared, state-of-the-art research instrument or system, from $300,000 up to $5,000,000, consolidating three older instrumentation programs.

Open

Funds an early-stage investigator's pivot into a genuinely new research direction, for a project with no preliminary data at all.